Ruffles Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 14.95%
- Ebitda 62.55%
- Net Worth -22.20%
- Total Assets -18.62%
About Ruffles Pharma
Ruffles Pharma Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 1998 and has a history of 26 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Akhileshwar Jha and Amit Jha serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85120DL1998PTC093317
- Company No.
093317
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 1998
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Ruffles Pharma Private Limited offer?
Ruffles Pharma Private Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Ruffles Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akhileshwar Jha  | Director | 14-Sep-2015 | Current |
| Amit Jha | Director | 18-Mar-2019 | Current |
Financial Performance of Ruffles Pharma.
Ruffles Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 14.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ruffles Pharma?
In 2019, Ruffles Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ruffles Pharma?
Unlock and access historical data on people associated with Ruffles Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ruffles Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruffles Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
